IntelliSep
Early detection of sepsis with organ dysfunction
Key Facts
About Cytovale
Cytovale is a commercial-stage diagnostics company addressing the critical unmet need for rapid, objective sepsis detection. Its flagship product, the IntelliSep test, runs on the proprietary Cytovale System and provides emergency department clinicians with a probability of sepsis with organ dysfunction within 3 days in about 8 minutes, enabling faster therapeutic intervention. The company's innovative approach leverages deformability cytometry to analyze immune cell biomechanics, offering a novel biomarker for sepsis. Cytovale is positioned to improve patient outcomes, reduce mortality, and increase hospital operational efficiency by transforming sepsis diagnosis from a clinical guess into a data-driven decision.
View full company profile